Manufacturing

Treatment Ready within 7 Days

Manufacturing takes place at Hemostemix’s state-of-the art facilities in Israel, and results in the ability to administer the product within 7 days of the initial cell collection. The final product is a mixture of cells packaged in ready-to-use syringes, with a 48-hour stable shelf life that does not require cryopreservation for transport.

Treatment Ready within 7 days